SCHEMBL17189529

SCHEMBL17189529

c1ccc(N(c2ccccc2)c2ccc(-n3c4ccccc4c4ccc5c(c6ccccc6n5-c5ccccc5)c43)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.50
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ ATM Q13315 1/20 0.50
▸ MAPK8 P45983 2/20 0.34
▸ JAK2 O60674 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ PTPN1 P18031 2/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ KMT2A Q03164 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31795 1.00 KDM4E (0.50) KDM4EL3MBTL1ATMMAPK8JAK2
SCHEMBL17019467 0.99 KDM4E (0.47) KDM4EL3MBTL1ATMMAPK8JAK2
SCHEMBL19863534 0.99 KDM4E (0.47) KDM4EL3MBTL1ATMMAPK8JAK2
SCHEMBL18505027 0.96 L3MBTL1 (0.46) KDM4EL3MBTL1ATMMAPK8JAK2
SCHEMBL24252004 0.95 L3MBTL1 (0.45) KDM4EL3MBTL1ATMMAPK8JAK2
SCHEMBL16773634 0.95 KDM4E (0.45) KDM4EL3MBTL1ATMMAPK8JAK2
SCHEMBL17426374 0.93 KDM4E (0.46) KDM4EL3MBTL1ATMMAPK8JAK2
SCHEMBL15582828 0.93 KDM4E (0.46) KDM4EL3MBTL1ATMMAPK8JAK2
SCHEMBL31869 0.93 L3MBTL1 (0.46) KDM4EL3MBTL1ATMMAPK8JAK2
SCHEMBL16870022 0.92 KDM4E (0.44) KDM4EL3MBTL1ATMMAPK8JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021129337-A1 ORGANIC COMPOUND AND ORGANIC ELECTRONIC DEVICE 广州华睿光电材料有限公司 2021-07-01 — — WO disclosed
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 — — US disclosed
EP-2933851-B1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2017-05-10 — — EP disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 — — US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 — — US disclosed
EP-2933851-A1 ORGANIC ELECTRICAL FIELD LIGHT-EMITTING ELEMENT Nippon Steel & Sumikin Chemical Co., Ltd. (JP) 2015-10-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 KDM4E 1228/4885L3MBTL1 74/4885ATM 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback